Drug Prices Will See More Moderate Increase But Specialty Million-Dollar Therapies Still Driving Costs Higher

"Hospitals and patients are still getting killed by new million-dollar drugs that won't see any competition for decades," said Dan Kistner, group senior vice president of pharmacy solutions for Vizient. In other pharmaceutical news: Roche posts its growth report, Novartis' gene therapy for infants continues to perform well, CVS figures out a way to help with diabetes medication costs, and scientists dig into the phenomenon of biotech's "missing girls."

from Kaiser Health News https://ift.tt/315MD6A